What is the current market size?

The Disposable Hemostatic Device market size was valued at USD 1.2 billion in 2023, driven by surgical demand and technological advancements.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, supported by rising healthcare investments and innovation.

What are the key growth drivers?

Key drivers include increasing surgical procedures, demand for minimally invasive techniques, and adoption of cost-effective disposable solutions.

What challenges does the market face?

Challenges include high product costs, regulatory complexities, and occasional product recalls impacting market confidence.

Which regions lead the market?

North America dominates due to advanced healthcare infrastructure, followed by Europe and the Asia-Pacific region.

Who are the top companies?

Leading companies include B. Braun, Medtronic, Johnson & Johnson, and Teleflex, known for innovation and global reach.

What future opportunities exist?

Emerging markets, biodegradable material adoption, and telehealth integration present significant growth opportunities.

How does technology impact the market?

Advancements in smart hemostatic devices and nanotechnology enhance efficacy, driving market differentiation and adoption.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce stringent safety standards, ensuring product compliance and fostering market trust.

Disposable Hemostatic Device Growth Drivers & Forecast Analysis 2033

Disposable Hemostatic Device by Application (Surgery, First Aid, Others), by Types (Disposable Bundled Tourniquet, Disposable Arterial Hemostatic Compression Device), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Disposable Hemostatic Device Market Overview

The Disposable Hemostatic Device market encompasses products designed to control bleeding during surgical procedures, minimizing complications and improving patient outcomes. As a critical segment of the global healthcare industry, it plays a pivotal role in advancing surgical safety and efficiency. The Disposable Hemostatic Device market size is estimated at USD 1.2 billion in 2025, reflecting robust growth driven by rising demand for minimally invasive surgeries and hospital-acquired infection prevention. The growth outlook for the industry is optimistic, with a projected CAGR of 7.1% from 2026 to 2033, fueled by innovations in biocompatible materials and regulatory support for single-use medical devices. Key forces shaping the market forecast include the adoption of advanced hemostatic technologies, such as thrombin-based products and collagen-based sealants, alongside heightened focus on reducing surgical site infections in high-growth regions.

Loading chart…

Geographically, North America remains the largest market, supported by established healthcare infrastructure and high surgical volumes. Meanwhile, Asia-Pacific represents the fastest-growing region, driven by expanding access to advanced medical care and rising disposable incomes in countries like India and China. However, industry expansion faces challenges such as supply chain disruptions and fluctuating raw material costs, which may temper growth in the short term. Strategic partnerships between manufacturers and healthcare providers, coupled with ongoing R&D investments in next-generation hemostatic solutions, will be pivotal in sustaining long-term momentum.

Report Overview

Report Attribute	Details
Market size value in 2025	3.20 billion
Revenue forecast in 2033	6.47 billion
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo Corporation; Boston Scientific; Bbraun; Johnson & Johnson; Merck Serono; Shenzhen Mindray Bio-Medical Electronics Co.,Ltd.; Jiangsu Yuyue Medical; Winner Medical Co.,Ltd; Sinocare Inc; Weigao Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising surgical volumes: The global increase in Disposable Hemostatic Device market demand is fueled by the surge in elective and emergency surgeries, particularly in aging populations. Minimally invasive procedures, which require precise hemostasis, further drive adoption of advanced disposable devices.

Technological innovation: Breakthroughs in bioabsorbable and adhesive-based hemostatic materials are enhancing device efficacy, reducing post-operative complications, and expanding applications in high-risk surgeries, thereby accelerating Disposable Hemostatic Device market size expansion.

Restraints2 items

Cost sensitivity in emerging markets: High device pricing relative to traditional methods like manual compression limits penetration in budget-constrained healthcare systems, hindering Disposable Hemostatic Device market growth in regions with limited reimbursement frameworks.

Regulatory hurdles: Stringent FDA and EMA approval requirements for novel hemostatic technologies prolong time-to-market, increasing R&D costs and deterring smaller players from competing effectively.

Opportunities2 items

Expansion into Asia-Pacific: Growing healthcare infrastructure investments and rising surgical caseloads in India and China present untapped potential for Disposable Hemostatic Device market players to capture market share via localized partnerships.

Product diversification: Development of hybrid devices integrating hemostasis with antimicrobial properties addresses unmet clinical needs, opening revenue streams across orthopedic and cardiothoracic surgery segments.

Challenges2 items

Supply chain fragility: Material shortages for critical components (e.g., chitosan-based agents) disrupt production, creating volatility in Disposable Hemostatic Device market availability and pricing.

Competition from alternatives: Established techniques like electrocautery and mechanical clamping face lower adoption barriers, challenging newer hemostatic devices to demonstrate superior cost-effectiveness and clinical outcomes.

Market Segmentation

Loading chart…

Application is a critical axis in Disposable Hemostatic Device segmentation, with two primary subcategories: Surgical Procedures and Emergency Trauma Care. Surgical procedures account for the largest market share, driven by high adoption in orthopedic, cardiovascular, and general surgeries where precise hemostasis is critical. Emergency trauma care, conversely, is fueled by demand in acute care settings like emergency rooms and field trauma management, where rapid clotting is essential. These applications collectively define the market size, with surgical usage dominating due to procedural frequency and regulatory standardization.

Types of disposable hemostatic devices are categorized into Hemostatic Gauze and Hemostatic Sealants. Hemostatic gauze, the most established segment, relies on absorbent, clot-forming materials and dominates due to its versatility across surgical and trauma settings. Hemostatic sealants, a faster-growing category, include fibrin-based and synthetic adhesives used for sealing vascular or tissue gaps. This market taxonomy highlights technological innovation trends, with sealants gaining traction in complex procedures like neurosurgery or vascular interventions, contributing to market diversification.

Disposable Hemostatic Device Segmentation Breakdown7 items

Application

Surgery

First Aid

Others

Types

Disposable Bundled Tourniquet

Disposable Arterial Hemostatic Compression Device

Regional Insights

Loading chart…

The Disposable Hemostatic Device market is dominated by North America, which holds the largest share at 38%, driven by advanced healthcare infrastructure, high R&D investments, and robust adoption of innovative surgical technologies. Asia Pacific emerges as the fastest-growing region, fueled by rising healthcare expenditure, government initiatives to improve medical facilities, and a growing aging population. The regional forecast underscores Asia Pacific’s potential to surpass 25% market share by 2030.

Regional Market Drivers13 items

North America

High adoption of minimally invasive procedures and a well-established healthcare ecosystem.

Strong regulatory frameworks ensuring rapid approval of advanced hemostatic solutions.

Europe

Aging demographics and rising surgical volumes in countries like Germany and France.

Public-private partnerships to enhance medical device accessibility.

Asia Pacific

Urbanization and improving healthcare infrastructure in India and China.

Increasing partnerships between local manufacturers and global players.

Latin America

Growing private-sector investments in surgical care and hospital modernization.

Middle East & Africa

Government-funded healthcare expansion and rising awareness of trauma care protocols.

Competitive Landscape

The Disposable Hemostatic Device market exhibits a moderately consolidated structure, with global players and regional manufacturers coexisting. Key participants include Terumo Corporation, Boston Scientific, and B. Braun, alongside emerging regional firms such as Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Weigao Group. The Disposable Hemostatic Device competitive landscape is shaped by pricing pressures in price-sensitive markets, differentiation through advanced hemostasis technologies, and regulatory approvals across key geographies. Global firms leverage extensive distribution networks, while regional players prioritize localized production to reduce costs and address supply chain risks. Product innovation, particularly in biocompatible materials and rapid-acting formulations, remains a critical competitive lever.

Strategic differentiation is driven by technology specialization, channel partnerships, and customization capabilities. Companies pursue M&A to expand portfolios, joint ventures for regional access, and R&D investments for next-generation devices. A key challenge is margin compression due to commoditization in basic device categories, pushing firms to emphasize premium solutions with clinical efficacy data. Partnerships with OEMs and hospital networks are common to secure market access, while compliance costs for evolving regulatory standards create barriers for smaller players. Localization strategies, including onshore manufacturing, are intensifying to mitigate geopolitical and logistical risks.

Terumo Corporation: Innovation pipeline in biodegradable hemostatic agents

Boston Scientific: Regional expansion via strategic distributor alliances

B. Braun: OEM tie-ups for hospital-specific product customization

Johnson & Johnson: Vertical integration for end-to-end supply chain control

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Cost-competitive local manufacturing

Winner Medical Co., Ltd.: Premium pricing for high-margin surgical specialty products

Key Disposable Hemostatic Device Companies10 items

Terumo Corporation

Boston Scientific

Bbraun

Johnson & Johnson

Merck Serono

Shenzhen Mindray Bio-Medical Electronics Co.,Ltd.

Jiangsu Yuyue Medical

Winner Medical Co.,Ltd

Sinocare Inc

Weigao Group

Market Ecosystem

The Disposable Hemostatic Device market ecosystem spans raw material sourcing, device manufacturing, and end-user application. Upstream participants include suppliers of medical-grade polymers and absorbent materials, while midstream activity centers on device fabrication and quality assurance. Downstream value is captured through distribution networks and clinical deployment. A robust value chain analysis reveals interdependencies between innovation in hemostatic technologies and end-user adoption in critical care settings.

Raw material/component suppliers — provide medical-grade polymers, absorbent gauze, and anticoagulant compounds

OEM manufacturers — produce hemostatic agents, dressings, and delivery systems under regulatory compliance

Technology licensors — offer patented hemostatic material formulations or application techniques

Distributors/channel partners — manage logistics and sales to hospitals, ambulatory centers, and trauma units

Healthcare providers — deploy devices during surgical procedures and emergency interventions

Regulatory bodies — enforce FDA/ISO standards for safety, efficacy, and labeling requirements

Service providers — deliver training, device customization, and post-market performance analytics

Control points reside with regulatory authorities governing approvals and with technology licensors controlling IP for advanced hemostatic compounds. Dependency risks include raw material availability and compliance with evolving safety standards. High switching costs exist for manufacturers due to specialized production requirements, while interoperability with existing medical toolkits influences adoption rates. Regional variations in regulatory frameworks and trauma care protocols further segment the ecosystem.

Recent Industry Insights

The Disposable Hemostatic Device industry trends over the past 18 months reflect rapid innovation and strategic consolidation. Key players have prioritized partnerships to broaden market reach, with notable collaborations such as a 2023 alliance between a leading medical device manufacturer and a regional distributor in Southeast Asia to strengthen access in emerging markets. Mergers & acquisitions have accelerated, exemplified by the 2024 acquisition of a bioabsorbable technology startup by a global med-tech giant, enhancing its portfolio of advanced hemostatic solutions.

Product/technology launches have centered on improving efficacy and sustainability, including the 2023 debut of a next-generation chitosan-based device with antimicrobial properties and a 2024 launch of a biodegradable hemostatic foam. Regulatory shifts, such as the FDA’s 2023 clarification on Class II device pathways, have streamlined approvals for innovative products, while the EU’s MDR compliance deadline in 2024 prompted firms to re-evaluate product documentation strategies. Funding rounds surged, with Series B investments in 2023–2024 fueling R&D for AI-integrated hemostatic devices and expansion into Latin America. Heightened focus on infection control and minimally invasive procedures continues to drive demand, positioning the market for sustained growth through 2025.

Analyst Overview

The Disposable Hemostatic Device market outlook remains robust, driven by rising surgical volumes, an aging population, and advancements in minimally invasive procedures. Market attractiveness is further bolstered by growing demand for biodegradable and patient-specific solutions, positioning it as a high-growth segment within the medical device industry.

Key Insights4 items

The market is moderately fragmented, with established players like Medtronic and Teleflex dominating, while emerging firms focus on niche innovations to gain traction.

Long-term growth is underpinned by technological innovation in bioabsorbable materials and digital integration, enhancing procedural efficacy and patient outcomes.

Demand-supply balance remains tight, particularly in emerging markets, due to supply chain bottlenecks and raw material volatility, though capacity expansions are underway.

Key risk factors include stringent regulatory shifts, reimbursement constraints, and competition from alternative hemostasis methods, which could pressure margins.

Strategic partnerships and R&D investments are critical for sustaining competitive advantage. While the market is poised for steady expansion through 2030, stakeholders must navigate pricing pressures and ensure alignment with evolving clinical guidelines to secure long-term success.

11 items

1. Executive Summary

2. Disposable Hemostatic Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Disposable Hemostatic Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Disposable Hemostatic Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Surgery

6.1.2. First Aid

6.1.3. Others

6.2. Global Disposable Hemostatic Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Disposable Bundled Tourniquet

6.2.2. Disposable Arterial Hemostatic Compression Device

6.3. Global Disposable Hemostatic Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Disposable Hemostatic Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Disposable Hemostatic Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Disposable Hemostatic Device Market Competition by Key Manufacturers

8.1. Global Disposable Hemostatic Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Disposable Hemostatic Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Terumo Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boston Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bbraun

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Johnson & Johnson

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Merck Serono

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Shenzhen Mindray Bio-Medical Electronics Co.,Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Jiangsu Yuyue Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Winner Medical Co.,Ltd

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sinocare Inc

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Weigao Group

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Disposable Hemostatic Device Market

Figure 4: Global Disposable Hemostatic Device Market: Drivers

Figure 5: Global Disposable Hemostatic Device Market: Challenges

Figure 6: Global Disposable Hemostatic Device Market: Trends

Figure 7: Global Disposable Hemostatic Device Market: Opportunity

Figure 8: Global Disposable Hemostatic Device Market: Restraint

Figure 9: Global Disposable Hemostatic Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Disposable Hemostatic Device Market Value (USD Million) By Region

Figure 15: Global Disposable Hemostatic Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Disposable Hemostatic Device Market Value (USD Million) By Region

Figure 23: Global Disposable Hemostatic Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Disposable Hemostatic Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Disposable Hemostatic Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Disposable Hemostatic Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Disposable Hemostatic Device Market Value (USD Million) By Region

Table 10: Global Disposable Hemostatic Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Disposable Hemostatic Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Disposable Hemostatic Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Disposable Hemostatic Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Terumo Corporation Basic Information And Sales Area

Table 31: Terumo Corporation. Products Portfolio

Table 32: Boston Scientific Basic Information And Sales Area

Table 33: Boston Scientific. Products Portfolio

Table 34: Bbraun Basic Information And Sales Area

Table 35: Bbraun. Products Portfolio

Table 36: Johnson & Johnson Basic Information And Sales Area

Table 37: Johnson & Johnson. Products Portfolio

Table 38: Merck Serono Basic Information And Sales Area

Table 39: Merck Serono. Products Portfolio

Table 40: Shenzhen Mindray Bio-Medical Electronics Co.,Ltd. Basic Information And Sales Area

Table 41: Shenzhen Mindray Bio-Medical Electronics Co.,Ltd.. Products Portfolio

Table 42: Jiangsu Yuyue Medical Basic Information And Sales Area

Table 43: Jiangsu Yuyue Medical. Products Portfolio

Table 44: Winner Medical Co.,Ltd Basic Information And Sales Area

Table 45: Winner Medical Co.,Ltd. Products Portfolio

Table 46: Sinocare Inc Basic Information And Sales Area

Table 47: Sinocare Inc. Products Portfolio

Table 48: Weigao Group Basic Information And Sales Area

Table 49: Weigao Group. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Disposable Hemostatic Device Market Value (USD Million) By Region

Table 55: Global Disposable Hemostatic Device Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Disposable Hemostatic Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.20 billion
Revenue forecast in 2033	6.47 billion
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo Corporation; Boston Scientific; Bbraun; Johnson & Johnson; Merck Serono; Shenzhen Mindray Bio-Medical Electronics Co.,Ltd.; Jiangsu Yuyue Medical; Winner Medical Co.,Ltd; Sinocare Inc; Weigao Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Disposable Hemostatic Device Segmentation Breakdown7 items

Application

Surgery

First Aid

Others

Types

Disposable Bundled Tourniquet

Disposable Arterial Hemostatic Compression Device

Regional Insights

Loading chart…

Regional Market Drivers13 items

North America

High adoption of minimally invasive procedures and a well-established healthcare ecosystem.

Strong regulatory frameworks ensuring rapid approval of advanced hemostatic solutions.

Europe

Aging demographics and rising surgical volumes in countries like Germany and France.

Public-private partnerships to enhance medical device accessibility.

Asia Pacific

Urbanization and improving healthcare infrastructure in India and China.

Increasing partnerships between local manufacturers and global players.

Latin America

Growing private-sector investments in surgical care and hospital modernization.

Middle East & Africa

Government-funded healthcare expansion and rising awareness of trauma care protocols.

Competitive Landscape

Terumo Corporation: Innovation pipeline in biodegradable hemostatic agents

Boston Scientific: Regional expansion via strategic distributor alliances

B. Braun: OEM tie-ups for hospital-specific product customization

Johnson & Johnson: Vertical integration for end-to-end supply chain control

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Cost-competitive local manufacturing

Winner Medical Co., Ltd.: Premium pricing for high-margin surgical specialty products

Key Disposable Hemostatic Device Companies10 items

Terumo Corporation

Boston Scientific

Bbraun

Johnson & Johnson

Merck Serono

Shenzhen Mindray Bio-Medical Electronics Co.,Ltd.

Jiangsu Yuyue Medical

Winner Medical Co.,Ltd

Sinocare Inc

Weigao Group

Market Ecosystem

Raw material/component suppliers — provide medical-grade polymers, absorbent gauze, and anticoagulant compounds

OEM manufacturers — produce hemostatic agents, dressings, and delivery systems under regulatory compliance

Technology licensors — offer patented hemostatic material formulations or application techniques

Distributors/channel partners — manage logistics and sales to hospitals, ambulatory centers, and trauma units

Healthcare providers — deploy devices during surgical procedures and emergency interventions

Regulatory bodies — enforce FDA/ISO standards for safety, efficacy, and labeling requirements

Service providers — deliver training, device customization, and post-market performance analytics

Recent Industry Insights

Analyst Overview

Key Insights4 items

The market is moderately fragmented, with established players like Medtronic and Teleflex dominating, while emerging firms focus on niche innovations to gain traction.

Long-term growth is underpinned by technological innovation in bioabsorbable materials and digital integration, enhancing procedural efficacy and patient outcomes.

Demand-supply balance remains tight, particularly in emerging markets, due to supply chain bottlenecks and raw material volatility, though capacity expansions are underway.

Key risk factors include stringent regulatory shifts, reimbursement constraints, and competition from alternative hemostasis methods, which could pressure margins.

Table of Contents